InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001415889-23-005232 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-20 2023-03-16+ KNSA Tessari Eben COO M - OptEx — +4,946 119.0K +4% —
DM 2023-03-20 2023-03-16+ KNSA Tessari Eben COO F - Tax $11.26 -1,453 116.0K -1% -$16.4K
DM 2023-03-20 2023-03-16+ KNSA Tessari Eben COO M - OptEx $0.00 -4,946 3,928 -56% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Share 2023-03-16 M A 1,964 — 116,612 D — — (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
2 Common Class A Common Share 2023-03-20 F D 876 $11.12 118,141 D — —
3 Common Class A Common Share 2023-03-20 M A 2,982 — 119,017 D — — (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
4 Common Class A Common Share 2023-03-16 F D 577 $11.46 116,035 D — —
5 Derivative Restricted Share Unit 2023-03-20 M D 2,982 $0.00 0 D — · — to — 2,982 Class A Common Share (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs.
6 Derivative Restricted Share Unit 2023-03-16 M D 1,964 $0.00 3,928 D — · — to — 1,964 Class A Common Share (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.